1542-46-7

Basic information

• Product Name: N,N-Bis(2-chloroethyl)-p-fluorobenzylamine
• Synonyms: N,N-Bis(2-chloroethyl)-p-fluorobenzylamine
• CAS NO: 1542-46-7
• Molecular Formula: C₁₁H₁₄Cl₂FN
• Molecular Weight: 250.14
• Mol File: 1542-46-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 247.6°Cat760mmHg
• Flash Point: 103.6°C
• Appearance: /
• Density: 1.214g/cm³
• Vapor Pressure: 0.0254mmHg at 25°C
• Refractive Index: 1.524
• CAS DataBase Reference: N,N-Bis(2-chloroethyl)-p-fluorobenzylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-Bis(2-chloroethyl)-p-fluorobenzylamine(1542-46-7)
• EPA Substance Registry System: N,N-Bis(2-chloroethyl)-p-fluorobenzylamine(1542-46-7)

Safety Data

• Hazardous Substances Data: 1542-46-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H14Cl2FN/c12-5-7-15(8-6-13)9-10-1-3-11(14)4-2-10/h1-4H,5-9H2

Upstream product

• 2995-38-2 2-[(4-fluoro-benzyl)-(2-hydroxy-ethyl)-amino]-ethanol 
• 352-32-9 p-fluorotoluene 
• 334-22-5 N,N-bis(chloro-2-ethyl)amine 
• 459-46-1 4-Fluorobenzyl bromide 
• 456-22-4 4-Fluorobenzoic acid 
• 352-11-4 1-chloromethyl-4-fluorobenzene 
• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 
• 403-43-0 4-fluorobenzoyl chloride 

Downstream Products

• 212770-98-4 1-(4-fluoro-benzyl)-4-(4-butoxy-benzenesulfonyl)-piperidine-4-carboxylic acid ethyl ester 
• 212770-96-2 1-(4-fluoro-benzyl)-4-(4-methoxy-benzenesulfonyl)-piperidine-4-carboxylic acid ethyl ester 

Relevant articles and documents

NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS

Provided herein are novel benzenesulfonamide compounds having a structure of formula (I) below: as well as to the method for synthesizing same and to the use thereof in pharmaceutical compositions to be used in human or veterinary medicine, as well as to

N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS

The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I), and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.